Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
#31 / 200 Total
SYRA - Syra Health Corp. - Stock Price Chart
CompanySyra Health Corp.
IndustryMedical Care Facilities
Market Cap20.61MEPS (ttm)-0.45
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S3.62EPS next 5Y-
P/B-EPS Q/Q-37.00%
Dividend-Sales Q/Q6.70%
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float0.03%EarningsNov 14/b
Analyst Recom-Target Price-
Avg Volume37.89K52W Range1.05 - 3.70
VIEW - View Inc. - Stock Price Chart
CompanyView Inc.
IndustryBuilding Products & Equipment
Market Cap7.37MEPS (ttm)-67.86
P/E-EPS this Y48.13%
Forward P/E-EPS next Y56.91%
PEG-EPS past 5Y-
P/S0.06EPS next 5Y-
P/B-EPS Q/Q-13786.02%
Dividend-Sales Q/Q60.85%
Insider Own33.26%Inst Own35.96%
Insider Trans-38.17%Inst Trans-58.21%
Short Float5.72%EarningsNov 14/a
Analyst Recom3.00Target Price180.00
Avg Volume1.10M52W Range0.62 - 95.40
VKTX - Viking Therapeutics Inc - Stock Price Chart
CompanyViking Therapeutics Inc
Market Cap1.75BEPS (ttm)-0.92
P/E-EPS this Y-3.19%
Forward P/E-EPS next Y-17.22%
PEG-EPS past 5Y-2.56%
P/S-EPS next 5Y40.00%
P/B4.76EPS Q/Q-9.46%
Dividend-Sales Q/Q-
Insider Own10.64%Inst Own75.58%
Insider Trans0.00%Inst Trans-0.34%
Short Float18.98%EarningsOct 25/a
Analyst Recom1.09Target Price33.80
Avg Volume2.15M52W Range3.54 - 25.72
VVOS - Vivos Therapeutics Inc - Stock Price Chart
CompanyVivos Therapeutics Inc
IndustryMedical Devices
Market Cap18.96MEPS (ttm)-14.70
P/E-EPS this Y55.85%
Forward P/E-EPS next Y59.76%
PEG-EPS past 5Y-18.88%
P/S1.31EPS next 5Y-
P/B411.24EPS Q/Q72.68%
Dividend-Sales Q/Q-22.26%
Insider Own16.80%Inst Own14.95%
Insider Trans24.00%Inst Trans-10.29%
Short Float3.85%EarningsNov 14/a
Analyst Recom1.00Target Price6.00
Avg Volume1.07M52W Range2.73 - 74.05
MLGO - MicroAlgo Inc - Stock Price Chart
CompanyMicroAlgo Inc
IndustrySoftware - Infrastructure
Market Cap16.18MEPS (ttm)0.01
P/E254.76EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.94EPS Q/Q-225.44%
Dividend-Sales Q/Q-
Insider Own93.69%Inst Own2.26%
Insider Trans0.00%Inst Trans-0.09%
Short Float44.83%Earnings-
Analyst Recom-Target Price-
Avg Volume1.71M52W Range1.12 - 71.50
SSNT - SilverSun Technologies Inc - Stock Price Chart
CompanySilverSun Technologies Inc
IndustrySoftware - Application
Market Cap48.39MEPS (ttm)-0.29
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y13.07%
P/S0.93EPS next 5Y-
P/B6.86EPS Q/Q-1438.31%
Dividend-Sales Q/Q22.96%
Insider Own41.50%Inst Own16.01%
Insider Trans-0.19%Inst Trans10.98%
Short Float1.77%Earnings-
Analyst Recom1.00Target Price5.00
Avg Volume662.26K52W Range2.54 - 13.37
HTOO - Fusion Fuel Green Ltd - Stock Price Chart
CompanyFusion Fuel Green Ltd
IndustryUtilities - Renewable
Market Cap17.90MEPS (ttm)-2.14
P/E-EPS this Y39.27%
Forward P/E-EPS next Y34.43%
PEG-EPS past 5Y-250.08%
P/S5.34EPS next 5Y-
P/B0.53EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own13.77%Inst Own22.87%
Insider Trans0.00%Inst Trans-
Short Float2.17%EarningsDec 04/b
Analyst Recom2.33Target Price2.82
Avg Volume222.51K52W Range0.50 - 6.60
AMPE - Ampio Pharmaceuticals Inc - Stock Price Chart
CompanyAmpio Pharmaceuticals Inc
Market Cap2.10MEPS (ttm)-12.05
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y34.16%
P/S-EPS next 5Y-
P/B0.38EPS Q/Q82.04%
Dividend-Sales Q/Q-
Insider Own9.68%Inst Own0.33%
Insider Trans139.93%Inst Trans-28.81%
Short Float2.06%Earnings-
Analyst Recom1.00Target Price600.00
Avg Volume353.76K52W Range1.86 - 8.30
REPL - Replimune Group Inc - Stock Price Chart
CompanyReplimune Group Inc
Market Cap377.99MEPS (ttm)-3.20
P/E-EPS this Y-17.40%
Forward P/E-EPS next Y-5.37%
PEG-EPS past 5Y-37.07%
P/S-EPS next 5Y-
P/B0.81EPS Q/Q-14.59%
Dividend-Sales Q/Q-
Insider Own26.61%Inst Own86.58%
Insider Trans-0.49%Inst Trans-0.85%
Short Float17.01%EarningsNov 07/b
Analyst Recom1.11Target Price48.44
Avg Volume801.10K52W Range9.79 - 29.52
Today 07:32AM UPDATE 1-Replimune's skin cancer drug fails in mid-stage study (Reuters) -48.05%
07:10AM CORRECTED-Replimune's skin cancer drug fails in mid-stage study (Reuters)
07:00AM Replimune Shares Initial Primary Analysis Results from CERPASS Clinical Trial in Advanced Cutaneous Squamous Cell Carcinoma and Presents New Data from IGNYTE Clinical Trial of RP1 in Anti-PD1 Failed Melanoma and Non-Melanoma Skin Cancers (GlobeNewswire)
Nov-13-23 09:55AM Forbion co-leads 129 million Series A financing of VectorY, one of the largest private biotech financings in Europe in 2023 (GlobeNewswire)
Nov-08-23 09:10AM Replimune Presents Updated Data on RP2 in Uveal Melanoma during Plenary Session at the 20th International Congress of the Society for Melanoma Research (GlobeNewswire) +6.56%
Nov-07-23 08:00AM Replimune Reports Fiscal Second Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire) -15.85%
Nov-03-23 07:30PM Replimune Presents Updated Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers During Oral Presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) (GlobeNewswire)
Oct-17-23 03:00AM Tessellate BIO Emerges from Stealth (GlobeNewswire)
Sep-19-23 04:01PM Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:00AM Replimune Announces Appointment of Emily Hill as Chief Financial Officer (GlobeNewswire)
GSIW - Garden Stage Limited Ordinary Shares - Stock Price Chart
CompanyGarden Stage Limited Ordinary Shares
CountryHong Kong
IndustryAsset Management
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume2.80M52W Range4.20 - 11.70